BSECompany Update17h ago · 23 Jul 2026, 12:53 pm

Board Meeting Outcome

TTK Healthcare Ltd-$ · 507747

✦ AI Summary▲ PositiveDivestiture

TTK Healthcare Ltd announced the sale of its 'EVA' and 'Good Home' brands to Wipro Enterprises Private Limited, with a consideration of Rs.256 crores. The transaction is subject to customary conditions and is expected to be completed by September 30, 2026.

Analysis Scores

Earnings Impact8/10
Growth Catalyst6/10
Governance Concern2/10
Regulatory Risk1/10
Balance Sheet Risk4/10
Liquidity Impact9/10
Market Sentiment8/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

TTK Healthcare Ltd-$ - 507747 - Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 Read With SEBI Master Circular Dated July 11, 2023

Attachments (1)

📄

14d43ba6-1fb1-41f0-a6ab-42d5f2b66a2e.pdf

pdf

Download →
View document text
TTKH:SEC:GJ:121:26 July 23, 2026 BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Exchange Plaza Dalal Street Bandra Kurla Complex, Bandra East Mumbai 400 001 Mumbai 400 051 Scrip Code: 507747 Scrip Code: TTKHLTCARE Dear Sirs, Re : Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Master Circular dated July 11, 2023 In compliance with the provisions of Regulation 30 of SEBI (LODR) Regulations, 2015, we hereby inform you that the Board of Directors in their meeting held today (July 23, 2026), based on the recommendation of the Audit Committee, approved the proposal for the sale of “EVA” and “Good Home” brands. Pursuant to this decision, the definitive agreements have been concluded with M/s Wipro Enterprises Private Limited, the Buyer, with the closing of the transaction contemplated thereunder being subject to the fulfilment of ‘conditions precedent’ that are customary in such transactions. The disclosure as required under SEBI Circular bearing No. SEBI/HO/CFD/PoD2/CIR/P/2023/120 dated July 11, 2023, is annexed herewith. The Board Meeting commenced at 12 noon and concluded at 12.45 p.m. Kindly take the above information on record. Thanking you Yours faithfully For TTK Healthcare Limited (GOWRY A JAISHANKAR) DGM – Legal & Company Secretary Encl.: a/a ANNEXURE 1. The amount and percentage of the turnover The Revenue / Turnover / Income from EVA and Good or revenue or income and net worth Home Brands for the FY 2025-26 was around Rs.148 crores contributed by such unit or division of the (17% of the total turnover of the Company). listed entity during the last financial year 2. Date on which the agreement for sale has The definitive agreements for the sale of EVA and Good been entered into Home Brands have been entered into on July 23, 2026, with the closing of the transaction contemplated thereunder being subject to the fulfilment of the ‘conditions precedent’ that are customary in such transactions. 3. The expected date of completion of sale / September 30, 2026, subject to the fulfilment of the disposal ‘conditions precedent’ that are customary in such transactions. 4. Consideration received from such sale / The total value of the consideration is Rs.256 crores disposal (Rupees Two Hundred and Fifty Six Crores Only) plus applicable GST. 5. Brief details of buyers and whether any of M/s Wipro Enterprises Private Limited. the buyers belong to the promoter / The Buyer does not belong to the Promoter Group of the promoter group / group companies. If yes, Company. details thereof 6. Whether the transaction would fall within No, the transaction does not fall within the ambit of related related party transactions? If yes, whether party transactions. the same is done at “arm’s length”. 7. Whether the sale, lease or disposal of the undertaking is outside a scheme of Not Applicable. arrangement? If yes, details of the same including compliance with Regulation 37A 8. Additional Disclosures being a slump sale The said transaction does not fall under the category of slump sale.